Bruce & Co’s Amryt Pharma AMYT Stock Holding History
Bought
Maintained
Sold
Other funds holding AMYT
Bruce & Co's AMYT Position: Q1 2023 in Review
Bruce & Co sold out of Amryt Pharma (AMYT) in Q1 2023, closing a stake of 315,182 shares — an estimated $2.3M sold.
Bruce & Co first reported a position in AMYT in Q3 2021 and held it in 6 quarters. The position peaked at $4.92M in Q3 2021. 79 funds tracked by Wall St. Rank hold AMYT as of Q1 2023.
- Bruce & Co reported no remaining Amryt Pharma position as of Q1 2023 after selling out during the quarter.
- Bruce & Co sold 315,182 Amryt Pharma shares in Q1 2023, an estimated $2.3M.
- Bruce & Co first reported a position in Amryt Pharma in Q3 2021 and held it in 6 quarters.
- Bruce & Co's Amryt Pharma position peaked at $4.92M in Q3 2021.
- 79 funds tracked by Wall St. Rank held Amryt Pharma as of Q1 2023.
Based on Bruce & Co's 13F filing for Q1 2023, filed 12 May 2023.